Triple Negative Breast Cancer (TNBC) is a subtype of breast cancer that does not express the genes for estrogen receptor (ER), progesterone receptor (PR), or HER2/neu. This means that TNBC does not respond to hormonal therapy or therapies that target HER2 receptors, which are common in other types of breast cancer.
